Meta Pixel

News and Announcements

Two steps forward, two steps back this month

  • Published March 31, 2022 12:00AM UTC
  • Publisher Wholesale Investor
  • Categories Company Updates

Aside from dealing with the impact of Covid and a couple more unexpected challenges over the last 2 years, we did not expect a war in Ukraine to be included on our risk register! Our two senior developers and team leads, from Ukraine, are out of action. They have important roles in quality control, peer review and general development. Additionally they have been managing the release process and working through the App Store submissions. They messaged us to say they are currently safe and in a bunker. 

Facing this unknown, Peter is working on getting another one or two developers however it takes time to recruit and get someone to come on board if they need to give notice, plus their ramp up time. As we don’t know how long Victor and Anton will be unavailable we need to take steps to cover ourselves. However we also need to be aware of the amount of ongoing developer commitments we make while we are working on a tight budget.

Losing Anton and Victor at this crucial time has also caused delays completing our App store submissions. So far we have put in 5 submissions to the Google Play Store and are working through the most recent issues they raised. We have covered most of the technical issues and are now modifying the Terms of Use to meet their needs. We have put our other developers onto the job now (which means their other work deploying the UI/UX is delayed) to put the submission into Apple and received feedback which they are working through now. Apple is known to be tougher when allowing products through to their App store so we hope this doesn’t take too long. 

We wanted to have ScreenCoach available through the App stores for our final larger Beta trial group and were hoping to commence next week, however this is likely to be delayed now. As soon as we’re past this, we will be getting our database onboarded. Below are the screenshots of how ScreenCoach will look in the App stores, we think they look awesome.

Capital Insights
The Ferrari of Immunotherapy: Chimeric’s High-Stakes Race to Cure Cancer

In the high-stakes world of biotechnology, the most sophisticated weapon against cancer isn’t a new chemical compound but the patient’s own immune system, re-engineered with the precision of a high-performance engine. “This particular CAR T is like a Ferrari,” says Dr. Rebecca McQualter, CEO of Chimeric Therapeutics (ASX: CHM). “It’s got two big engines on […]

Capital Insights
From Algae Pioneers to a Natural Revolution: The Second Act of WRS Bioproducts

As the US FDA prepares to phase out synthetic food colors by the end of 2026, WRS Bioproducts is stepping in to solve a looming supply crisis. Led by industry pioneer Harry Rosen, the company is leveraging 40 years of industrial algae farming expertise to scale production of natural, superior-quality beta-carotene, positioning itself as a vital supplier in the rapidly shifting global market for natural ingredients.

Join over 45,000+ sophisticated investors

Join Now